Hemoglobin F concentration as a function of age in Kuwaiti sickle cell disease patients

Medical Principles and Practice

Volumn 16, Issue 4, 2007, Pages 286-290

  Adekile, Adekunle ^a   Al Kandari, Mohammed ^b   Haider, Mohammad ^a   Rajaa, Marouf ^a   D'Souza, Mark ^a   Sukumaran, Jalaja ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

^b Mubarak Hospital   (Kuwait)

Author keywords

Hemoglobin F, age; Hemoglobin F, Kuwait; Sickle cell disease

Indexed keywords

ALPHA GLOBIN; HEMOGLOBIN A2; HEMOGLOBIN F; HEMOGLOBIN S;

ADULT; AGE; AGE DISTRIBUTION; ALPHA THALASSEMIA; ARTICLE; BETA THALASSEMIA; ERYTHROCYTE COUNT; FEMALE; GENOTYPE; GROUPS BY AGE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR VOLUME; MEDICAL RECORD; POLYMERASE CHAIN REACTION; SEX RATIO; SICKLE CELL ANEMIA; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; AGE FACTORS; ALPHA-THALASSEMIA; ANEMIA, SICKLE CELL; CHILD; CHILD, PRESCHOOL; FEMALE; FETAL HEMOGLOBIN; GENOTYPE; HUMANS; INFANT; KUWAIT; MALE; MIDDLE AGED; SEX FACTORS;

EID: 34249801503     PISSN: 10117571     EISSN: None     Source Type: Journal    
DOI: 10.1159/000102151     Document Type: Article

References (27)

1. Powars DR, Weiss JN, Chan LS, Schroeder WA: Is there a threshold level of fetal hemoglobin that ameliorates morbidity in sickle cell anemia? Blood 1984;63;921-926.
2. Powars DR: Sickle cell anemia: beta S-gene-cluster haplotypes as prognostic indicators of vital organ failure. Semin Hematol 1991;28:180.
3. 2 in sickle cell anemia and some related disorders. Am J Clin Pathol 1974;61:375-381.
4. Adekile AD, Huisman THJ: Hb F in sickle cell anaemia. Experientia 1993;49:16-27.
5. Nagel RL and Ranney HM: Genetic epidemiology of the β-globin gene. Semin Hematol 1990;27:332-349.
6. Dover GJ, Chang VT, Boyer SH, Serjeant GR, Antonarakis SE, Higgs DR: The cellular basis for different fetal hemoglobin levels among sickle cell individuals with two, three and four α-globin genes. Blood 1987;69:341-344.
7. Steinberg MH, Rosenstock W, Coleman MB, Adams JG, Platica O, Cedeno M, Rieder RF, Wilson JT, Milner P, West S: Effects of thalassemia and microcytosis on the hematologic and vasoocclusive severity of sickle cell anemia. Blood 1984;63:1353-1360.
8. Morris J, Dunn D, Beckford M, Grandison Y, Mason K, Higgs DR, De Ceulear K, Serjeant BE, Serjeant GR: The haematology of sickle cell disease after the age of forty years. Br J Haematol 1991;77:382-385.
9. Adekile AD, Gu L-H, Baysal E, Haider MZ, Al-Fuzae L, Aboobacker KC, Al-Rashied A, Huisman THJ: Molecular characterization of α-thalassaemia determinants, β-thalassaemia alleles and βS haplotypes among Kuwaiti Arabs. Acta Haematol 1994;92:176-181.
10. S haplotype and α-globin gene patterns among sickle cell anemia patients in Kuwait. Acta Haematol 1996;96:150-154.
11. Adekile AD, Gupta R, Yacoub F, Sinan T, Al-Bloushi M, Haider MZ: Avascular necrosis of the hip in Kuwaiti children with sickle cell disease: MRI images and association with α-thalassemia trait. Acta Haematol 2001;105:27-31.
12. Adekile AD, Yacoub F, Gupta R, Sinan T, Al-Bloushi M, Haider MZ, Habib Y, Moosa A: Silent brain infarcts are rare in Kuwaiti children with sickle cell disease and elevated Hb F. Am J Hematol 2002;70:228-231.
13. Adekile AD, Owunwanne A, Al-Za'abi K, Haider MZ, Tuli M, Al-Mohannadi S: Temporal sequence of splenic dysfunction in sickle cell disease. Am J Hematol 2002;69:23-27.
14. Bissé E, Wieland H: High-performance chromatographic separation of human haemoglobins: simultaneous quantitation of foetal and glycated haemoglobins. J Chromatogr 1988;434:95-110.
15. Poncz M, Solowiejczyk D, Harpel B, Mory Y, Schwartz E, Surrey S: Construction of human gene libraries from small amounts of peripheral blood: analysis of β-like globin genes. Hemoglobin 1982;6:27-36.
16. S chromosomes with five different haplotypes. Blood 1991;77:2488-2496.
17. Baysal E, Huisman THJ: Detection of common deletional α-thalassemia-2 determinants by PCR. Am J Hematol 1994;46:208-213.
18. Ohene-Frempong K.: Stroke in sickle cell disease: demographic, clinical, and therapeutic considerations. Semin Hematol 1991;28:213-219.
19. Moser FG, Miller ST, Bello JA, Pegelow CH, Zimmerman RA, Wang WC, Ohene-Frempong K, Schwartz A, Vichinsky EP, Gallagher D, Kinney TR: The spectrum of brain MR abnormalities in sickle cell disease: a report from the cooperative study of sickle cell disease. AJNR 1996;17:965-972.
20. Marouf R, Gupta R, Haider MZ, Adekile AD: Silent brain infarcts in adult Kuwaiti sickle cell disease patients. Am J Hematol 2003;73:240-243.
21. Ohene-Frempong K, Weiner SJ, Sleeper LA, Miller ST, Embury S, Moohr JW, Wethers DL, Pegelow CH, Gill FM: Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 1998;91:288-294.
22. Pearson HA, Spencer RP, Cornelius EA: Functional asplenia in sickle cell anemia. N Engl J Med 1969;282:923-926.
23. Adekile AD, Tuli M, Haider MZ, Al-Zaabi K, Al-Mohannadi S, Owunwanne O: Influence of α-thal trait on spleen function in sickle cell anemia patients with high HbF. Am J Hematol 1996;53:1-5.
24. Stamatoyannopoulus G: Control of globin gene expression during development and erythroid differentiation. Exp Hematol 2005;33:259-271.
25. Styles LA, Hoppe C, Klitz W, Vichinsky E, Lubin B, Trachtenberg E: Evidence for HLA related susceptibility for stroke in children with sickle cell disease. Blood 2000;95:3562-3567.
26. Chui DHK, Dover GJ: Sickle cell disease: no longer a single gene disorder. Curr Opin Pediatr 2001;13:22-27.
27. Kutlar A: Sickle cell disease: a multigenic perspective of a single gene disorder. Med Princ Pract 2005;14:15-19.